متابعة القراءة
المقال الكامل على Unknown
Co-Diagnostics Announces Reverse Stock Split
تحليل معلومات السوق
مدعوم بالذكاء الاصطناعي
لماذا هذا مهم
Co-Diagnostics, Inc. has announced a 1-for-30 reverse stock split to become effective on January 2, 2026, which may lead to increased stock price and reduced share count, potentially improving the company's market appearance.
تأثير السوق
Market impact analysis based on bullish sentiment with 80% confidence.
المشاعر
Bullish
ثقة الذكاء الاصطناعي
80%
الأفق الزمني
قصير الأجل
سياق المقال
ملاحظة: هذا مقتطف موجز للسياق. انقر أدناه لقراءة المقال الكامل على المصدر الأصلي.
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has filed a Certificate of Amendment to its Certificate of Incorporation (the "Amendment") to effect a reverse stock split of its common stock at a ratio of 1-for-30 shares. The reverse stock split will become effective at 12:01 a.m. ET on Friday, January 2, 2026. Co-Dx's common stock will conti
المقال الأصلي منشور بواسطة
Unknown
في ديسمبر 30, 2025.
التحليل والرؤى المقدمة من AnalystMarkets AI.
التحليل والرؤى المقدمة من AnalystMarkets AI.